NCT02063555View on ClinicalTrials.gov

Phase I Trial of DAR-901

PHASE1CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

June 30, 2016

Conditions
Tuberculosis
Interventions
BIOLOGICAL

DAR-901

BIOLOGICAL

BCG

BIOLOGICAL

Sterile saline

Trial Locations (1)

03756

Dartmouth-Hitchcock Medical Center, Lebanon

Sponsors

Collaborators (1)

Aeras
All Listed Sponsors
collaborator

Aeras

OTHER

lead

Dartmouth-Hitchcock Medical Center

OTHER